Table 5.

Multivariable analysis: competing risk regression for LC, Cox regression for lung PFS and OS (distant PFS . Hazard ratio and p-value are reported only for the variables included in the multivariable analysis

Endpoint	Local control	Lung PFS		Overall survival
Variables	Hazard ratio (95% CI)	p value	Hazard ratio (95% CI)	p value	Hazard ratio (95% CI)	p value
Primary histology (adeno vs other)	0.75 (0.28–2.02)	0.57	0.54 (0.28–1.07)	0.078	0.57 (0.22–1.50)	0.25
Primary tumor site (reference: Lung)
GI vs Lung	0.55 (0.14–2.09)	0.38	0.90 (0.43–1.88)	0.77	0.29 (0.08–1.02)	0.05
Other vs Lung	1.00 (0.39–2.53)	0.99	0.61 (0.27–1.38)	0.24	0.37 (0.11–1.31)	0.12
Prior chemotherapy (yes vs no)	3.01 (0.76–11.92)	0.12	/	/	/	/
Age > 65 (yes vs no)	0.64 (0.24–1.67)	0.36	/	/	/	/
Performance status(1+ vs 0)	4.00 (0.86–18.64)	0.077	/	/	2.46 (0.56–10.74)	0.23
Gender (male vs female)	2.17 (0.86–5.44)	0.10	/	/	/	/
GTV volume (> 10 cc vs < 10 cc)	1.92 (0.78–4.75)	0.16	/	/	/	/
BED prescription (> 120 Gy vs < 120 Gy)	0.35 (0.14–0.87)	0.025	/	/	/	/